TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Scandinavian ChemoTech AB
Closing information (x1000 NOK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
2,859
|
447
|
48 |
Financial expenses |
1,421
|
1,794
|
658 |
Earnings before taxes |
-21,366
|
-21,516
|
-17,303 |
EBITDA |
-17,786
|
-16,992
|
-13,908 |
Total assets |
15,063
|
20,527
|
25,170 |
Current assets |
7,292
|
11,179
|
13,103 |
Current liabilities |
3,888
|
7,292
|
1,846 |
Equity capital |
11,175
|
13,235
|
23,324 |
- share capital |
9,086
|
5,682
|
4,696 |
Employees (average) |
6
![]() |
6
|
7 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
74.2%
|
64.5%
|
92.7% |
Turnover per employee |
476
|
74
|
7 |
Profit as a percentage of turnover |
-747.3%
|
-4813.4%
|
-36047.9% |
Return on assets (ROA) |
-132.4%
|
-96.1%
|
-66.1% |
Current ratio |
187.6%
|
153.3%
|
709.8% |
Return on equity (ROE) |
-191.2%
|
-162.6%
|
-74.2% |
Change turnover |
2,380
|
401
|
-80 |
Change turnover % |
497%
|
865%
|
-63% |
Chg. No. of employees |
0
|
-1
|
0 |
Chg. No. of employees % |
0%
|
-14%
|
0% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.